Zebrafish models have transformed glioma research by offering a cost-effective, genetically tractable platform for studying tumor biology, identifying molecular pathways like RTK/Ras/PI3K, RB, and TP53, and conducting high-throughput drug screening. The gene discussed is TP53; the disease is central nervous system cancer.